S100A4 in cancer progression and metastasis: A systematic review
Fei Fei, Jie Qu, Mingqing Zhang, Yuwei Li, Shiwu Zhang
The protein S100A4 is linked to cancer spread and may be a useful biomarker and a target for new cancer therapies.
Metastasis is the leading cause of cancer-related death and directly associates with cancer progression, resistance to anticancer therapy, and poor patient survival. Current efforts focusing on the underlying molecular mechanisms of cancer metastasis attract a special attention to cancer researchers. The epithelial-mesenchymal transition is a complex of molecular program during embryogenesis, inflammation, tissue fibrosis, and cancer progression and metastasis. S100A4, an important member of S100 family proteins, functions to increase the tumor progression and metastasis. The molecular mechanisms of S100A4 involving in the progression and metastasis are diverse in various malignant tumors. Detection of S100A4 expression becomes a promising candidate biomarker in cancer early diagnosis and prediction of cancer metastasis and therefore, S100A4 may be a therapeutic target. This review summarized up to date advancement on the role of S100A4 in human cancer development, progression, and metastasis and the underlying molecular events and then strategies to target S100A4 expression experimentally.
The first episode of the English podcast “The Fascia Guide”. The Fascia Guide is a podcast about the living body, about new research and a new perspective on health, pain and what…
The episode was first published on the Swedish podcast Fasciaguiden on June 4, 2025. In this unique episode, we meet Professor Gerald Pollack — one of the world’s most influential…